XML 37 R18.htm IDEA: XBRL DOCUMENT
v3.24.4

Concentrations | 12 Months Ended
--- | ---
Sep. 30, 2024
Concentrations [Abstract] |
Concentrations | NOTE 11 - Concentrations Revenue For the year ended September 30, 2024, one customer accounted for 90% of the Company’s product revenue and three customers accounted for the remaining 10% of product revenue. For the year ended September 30, 2023, one customer accounted for all of the Company’s product and collaborations revenue. Supplier concentration One contract manufacturer produces all of the Company’s Strip/Grid Products and sEEG Products and another supplier was responsible for the development of the Company’s OneRF Ablation system.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/275/tableOfContent + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration